Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 14, 2015 · 10-Q · 45 days after period end · 0001062993-15-004580
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | -$4.24M | -$1.01M | -$151.92K | -$4.54M |
| EPS Diluted | -$0.22 | -$0.03 | -$0.01 | -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 14, 2015 · 45 d after period end
